Antibody–PROTAC conjugates enable HER2-dependent targeted protein degradation of BRD4
M Maneiro, N Forte, MM Shchepinova… - ACS chemical …, 2020 - ACS Publications
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
[PDF][PDF] Antibody− PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
M Maneiro, N Forte, MM Shchepinova, CS Kounde… - 2020 - marinbio.com
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4.
MA Maneiro, N Forte, MM Shchepinova… - ACS Chemical …, 2020 - europepmc.org
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
[引用][C] Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
M Maneiro, N Forte, MM Shchepinova… - ACS Chemical …, 2020 - cir.nii.ac.jp
Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of
BRD4 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
BRD4 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[PDF][PDF] Antibody− PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
M Maneiro, N Forte, MM Shchepinova, CS Kounde… - scholar.archive.org
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
MA Maneiro, N Forte, MM Shchepinova… - ACS Chemical …, 2020 - discovery.ucl.ac.uk
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
[HTML][HTML] Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
M Maneiro, N Forte, MM Shchepinova… - ACS Chemical …, 2020 - ncbi.nlm.nih.gov
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
MA Maneiro, N Forte, MM Shchepinova… - ACS chemical …, 2020 - pubmed.ncbi.nlm.nih.gov
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
Antibody-PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
MA Maneiro, N Forte, MM Shchepinova… - ACS chemical …, 2020 - pubmed.ncbi.nlm.nih.gov
Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of
great current interest in drug discovery. Nevertheless, although the high effectiveness of …
great current interest in drug discovery. Nevertheless, although the high effectiveness of …